Edward A. Ageno Distinguished Professorship in Hematology/Oncology, UCSF
| CONTACT | |
|
(415) 353-2421 (appts) Box 0324, UCSF; San Francisco, CA 94143-0324 |
additional websites: |
| EDUCATION | |
|
Johns Hopkins University, 1957-1960, Biological Sciences
|
|
| PROFESSIONAL EXPERIENCE | |
|
1964-1965 |
Intern in Medicine, Strong Memorial Hospital, Rochester, NY |
|
1965-1966 |
Assistant Resident in Medicine, Strong Memorial Hospital, Rochester, NY |
|
1968-1969 |
Resident in Medicine (II), University of California Hospitals, San Francisco, CA |
|
1969-1970 |
Chief Resident in Medicine, University of California Hospitals (San Francisco General Hospital), San Francisco, CA |
|
1970-1972 |
Fellow in Hematology, University of California, San Francisco, CA |
|
1972-1976 |
Assistant Clinical Professor of Medicine, Laboratory Medicine, and Radiology (Nuclear Medicine), University of California, San Francisco, CA |
|
1972-1974 |
Chief, Hematology Clinic, University of California Medical Center, San Francisco, CA |
|
1974-1980 |
Director, Hematology & Oncology Clinics, University of California Medical Center, San Francisco, CA |
|
1976-1983 |
Associate Clinical Professor of Medicine and Laboratory Medicine, University of California, San Francisco, CA |
|
1989-1991 |
Director, Adult Bone Marrow Transplant Program, University of California Medical Center, San Francisco, CA |
|
1975-2002 |
Director, Outpatient Transfusion Service, University of California Medical Center, San Francisco, CA |
|
1980-2002 |
Director, Hematology/Oncology Faculty Practice, University of California Medical Center, San Francisco, CA |
|
1983-2003 |
Clinical Professor of Medicine, University of California, San Francisco, CA |
|
2003-present |
Clinical Professor of Medicine Emeritus, University of California, San Francisco, CA |
|
Military Service: |
|
|
1966-1968 |
Senior Assistant Surgeon, U.S. Public Health Service (Heart Disease Control Program) |
| HONORS & AWARDS | |
|
Edward Ageno Distinguished Professor of Hematology Oncology, UCSF |
|
| SELECTED PUBLICATIONS | |
|
Smith GA, Damon LE, Rugo HS, Ries CA, & Linker CA: High-dose Ara-C (HDAC) dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency. J Clin Oncol 15:833, 1997. | |
|
Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report. Bone Marrow Transplant 22:865-872, 1998. | |
|
Linker CA, Ries CA, Damon LE, Rubin A, Case D, Crilley P, Topolsky D, Brodsky I, Zamkoff K, Wolf J. Autologous stem cell transplantation for acute myeloid leukemia in first remission. Biology of Blood and Marrow Transplantation 6(1):50-57 (2000). | |
|
Damon LE, Wolf JL, Rugo HS, Gold E, Ries CA, Zander AR, Tracy M, Cecchi G, Irwin D, & Linker CA: High-dose chemotherapy for breast cancer: Improved results in patients with ten or more involved axillary lymph nodes. Bone Marrow Transpl Aug;26(3): 257-268, 2000. | |
|
Linker CA, Damon LE, Ries CA, Navarro W, Case D, Wolf J. Autologous stem cell transplant for advanced acute myeloid leukemia. Bone Marrow Transplant. 2002 Feb;29(4):297-301. | |
|
Linker C, Damon L, Ries C, Navarro W. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. J Clin Oncol. 2002 May 15;20 (10):2464-71. |
|
|
7/21/08 |
|


